Renal fibrosis is the common anatomical feature underlying the progression of chronic kidney disease, a leading cause of morbidity and mortality worldwide. In a previous study, we demonstrated that during development of renal fibrosis in a rat model of unilateral ureteric obstruction, calreticulin (CRT) is up-regulated in tubular epithelial cells (TECs). In the present study, we used in vitro and in vivo approaches to examine the role of CRT in TECs and its contribution to the progression of fibrosis. In cultured renal TECs, CRT overexpression induced acquisition of an altered, profibrotic cellular phenotype. Consistently, the opposite effects were observed for CRT knockdown. Subsequently, we confirmed that critical changes observed in vitro were also apparent in tubular cells in vivo in the animal model of unilateral ureteric obstruction. In agreement with these results, we demonstrate that substantial (50%) reduction in the expression of CRT reduced the development of tubulointerstitial fibrosis at a comparable level through regulation of inflammation, transcriptional activation, transforming growth factor b1eassociated effects, and apoptosis. In summary, our findings establish that CRT is critically involved in the molecular mechanisms that drive renal fibrosis progression and indicate that inhibition of CRT expression might be a therapeutic target for reduction of fibrosis and chronic kidney disease development. (Am J Pathol 2013, -: 1e14; http://dx.doi.org/ 10.1016/j.ajpath.2013.07.014) Q7 Chronic kidney disease (CKD), leading eventually to renal failure and the need for replacement therapy, is frequently observed in all adult populations, affecting >10% of individuals. 1, 2 Although CKD is the end result of several renal and systemic diseases, its common anatomical feature is progressive development of fibrosis. This is a complex process involving many cell types, of which the phenotype becomes modified, and cascades of overlapping biochemical pathways. 3e6 Currently, several aspects of these events are poorly understood.
Previously we have performed proteomic analysis of renal parenchyma of the well-established rodent model of unilateral ureteric obstruction (UUO). 7, 8 Our initial studies indicated that calreticulin (CRT) is among the proteins that are consistently up-regulated from the earliest stages of the process of renal fibrosis, even before the extracellular matrix (ECM) begins to accumulate. 9 Up-regulation was confirmed at the protein and mRNA levels and was localized exclusively in tubular epithelial cells (TECs). 9 CRT is a multifunctional endoplasmic reticulum (ER) protein that acts as a molecular chaperone and Ca 2þ -binding molecule. However, it has also been found in other cellular compartments such as the cell surface and in the extracellular environment. Altered expression or localization of CRT alters cellular functions including the Ca 2þ storage capacity of ER, cell adhesiveness, proliferation and apoptosis, gene expression, and immune system function. 10, 11 Furthermore, it is essential for cardiac development and mouse embryogenesis. 12 Recent studies have implicated CRT in wound healing and chronic kidney transplant rejection. 11, 13 However, our initial observation was the first to involve CRT in the fibrotic process. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63 In the present study, using an in vitro approach, we investigated alterations in the cellular phenotype when CRT expression was increased in cultured renal TECs. We demonstrated that these cells acquired a more mesenchymal character reminiscent of initial steps of epithelialmesenchymal transition (EMT), exhibited excessive and selective ECM production, and showed increased ER stress and apoptosis. Consistently, significant reduction of CRT expression by shRNA-mediated knockdown suppressed both profibrotic and proinflammtory markers. Subsequently, we examined and confirmed that some of the observed changes in vitro were also apparent in tubular cells in vivo in the animal model of UUO. In addition, we evaluated the effect of drastic reduction in expression of CRT in heterozygous transgenic mice 14 on development of fibrosis in the UUO model and observed that reduction of CRT conferred substantial protection and attenuated the process of tubulointerstitial fibrosis.
Materials and Methods

Cell Culture
Human proximal TECs (HK-2) were purchased from ATCC (Manassas, VA). The cells were grown 1:1 in Dulbecco's modified Eagle's medium [4.5 g/L glucose and F-12 supplemented with 10% fetal bovine serum (FBS), 100 mg/mL penicillin-streptomycin, and 2 mmol/L L-glutamine] and were subcultured according to the manufacturer's instructions.
CRT-overexpressing HK-2 cell lines were generated via stable transfection of pcDNA3.1/hygro plasmid carrying mouse CRT cDNA (kindly provided by Dr. Yoshito Ihara, Wakayama Medical School, Japan). Control cells were transfected with the empty vector. In brief, HK-2 cells were transfected in six-well plates with pcDNA3.1-hygroemouse CRT or empty vector using lipofectamine 2000 transfection reagent (Invitrogen Corp., Carlsbad, CA). After 2 days, the cells were transferred to 10-mm culture dishes and grown in normal medium plus 200 mg/mL hygromycin B (Merck & Co., Inc., Whitehouse Station, NJ), which was renewed every 2 or 3 days. After 10 to 12 days, stable clones were removed and individually expanded. The expression level of CRT in each clone was examined via Western blotting. The selected clones were then maintained in normal growth medium supplemented with 100 mg/mL hygromycin.
CRT knockdown HK-2 cell lines were generated with stable transfection of pSuper.retro.puro vector carrying an shRNA sequence specific for human CRT. Control cells were transfected with the empty vector. In brief, shRNA sense and antisense sequences were annealed and cloned into pSuper.retro.puro vector in BglII-XhoI restriction sites. HK-2 cells were transfected in six-well plates with pSuper.retro.puro-CRT shRNA or empty vector, as above. Stable clones were selected in 2 mg/mL puromycin (AppliChem GmbH, Darmstadt, Germany). The expression level of CRT in each clone was examined via Western blotting.
The selected clones were then maintained in normal growth medium supplemented with 1 mg/mL puromycin. The sequences for human CRT-specific shRNA were as follows: 5 0 -GATCCCCGGAGCAGTTTCTGGACGGATTCAAGA-GATCCGTCCAGAAACTGCTCCTTTTTC-3 0 and 5 0 -TC-GAGAAAAAGGAGCAGTTTCTGGACGGATCTCTTGA-ATCCGTCCAGAAACTGCTCCGGG-3 0 . For transforming growth factor beta1 (TGF-b1) treatment of the CRT knockdown cells, the cells were incubated with or without 5 ng/mL TGF-b1 (Sigma
Q1
, St. Louis, MO) in serum-deprived medium for 48 hours, after which they were collected for Western blotting or quantitative RT-PCR (RTqPCR) analysis.
Animals
Eight-to 12-week-old male Wistar rats were supplied from the colony of our Center for Experimental Surgery. For the UUO model, rats underwent ligation of the right ureter, and sham-operated rats were used as controls, as described previously. 9 CRT heterozygous (CRT þ/À ) C57BL/6 mice, expressing only one functional CRT allele, and their wild-type (WT) littermates were provided by Dr. Marek Michalak (University of Alberta, Canada) and have been previously described.
14 For the UUO model, 12-week-old CRT þ/À and WT male mice underwent ligation of the right ureter, and the contralateral kidneys served as controls. All aspects of animal experimentation were performed in adherence to the NIH and the European Union Guide for the Care and Use of Laboratory Animals and were approved by the Institutional Review Board of the Biomedical Research Foundation of the Academy of Athens.
Western Blot Analysis
Proteins from cell cultures and tissue samples were extracted in radioimmunoprecipitation assay buffer [50 mmol/L Tris (pH 7.4), 1% NP-40, 0.25% deoxycholate (DOC), 150 mmol/L NaCl, 1 mmol/L Na 2 EDTA, 1 mmol/L phenylmethylsulfonyl fluoride, and cocktail protease inhibitors] and measured for protein concentration using the Bradford method, and equal protein amounts were loaded in an SDS-PAGE apparatus, followed by Western blotting. 125  126  127  128  129  130  131  132  133  134  135  136  137  138  139  140  141  142  143  144  145  146  147  148  149  150  151  152  153  154  155  156  157  158  159  160  161  162  163  164  165  166  167  168  169  170  171  172  173  174  175  176  177  178  179  180  181  182  183  184  185  186  187 For Col1A1 immunoblotting in conditioned medium, cells were cultured for 24 hours in normal growth medium and then in serum-deprived medium for 48 hours. Conditioned medium was then collected with protease inhibitors, centrifuged to pellet cells, and concentrated three times in a Concentrator 5301 (Eppendorf AG, Hamburg, Germany). Equal volumes from different samples were loaded in a normal SDS-PAGE apparatus, followed by Western blotting. For evaluation of Col1A1 levels separately in the cellular and ECM compartments, DOC separation of the fractions was performed according to the method of Van Duyn Graham et al. 15 
Q2
In brief, cells were seeded in six-well plates, cultured for 24 to 48 hours in normal growth medium, and then in serum-deprived medium for another 48 
RT-qPCR
Total RNA was prepared from cultured cells and mouse kidney tissue using TRI reagent (Molecular Research Center, Cincinnati, OH) according to manufacturer's instructions. For the cell preparations, cells were seeded in six-well plates in normal growth medium and were cultured for 48 to 72 hours until they were near confluence. The quality of the RNA was verified on agarose gels, and the quantity was measured using a Spectronic photometer (Thermo Fisher Scientific). Total RNA, 1 mg, was reverse transcribed using ImProm-II reverse transcriptase (Promega Corp., Madison, WI). We performed RT-qPCR using ABI Prism 7000 software Q4 (Applied Biosystems, Inc., Foster City, CA), with Platinum TaqDNA polymerase (Invitrogen), three-step standard cycling conditions, and sequencespecific primers. We performed a melting curve analysis to verify that a single product was amplified. For quantitative analysis, experimental genes were normalized to 18S rRNA or GAPDH gene expression using the DDCT method. The experiments were performed in triplicate and were repeated three times.
Proliferation Assay
Cell proliferation was studied using a BrdU-incorporation immunolabeling assay. Cells were seeded on coverslips and cultured for 24 to 48 hours. After 2 hours of incubation with BrdU solution, the cells were fixed in 4% paraformaldehyde, permeabilized with 2N HCl, blocked with 5% FBS, and incubated with a primary anti-BrdU antibody (ab6326; Abcam). A fluorescent secondary antibody (anti-rat Alexa Fluor; Invitrogen) was used for detection of the BrdUpositive signal. The cells were counterstained with DAPI for nuclei visualization and mounted on slides in Mowiol 4-88 reagent (Calbiochem, EMD Millipore, Billerica, MA). Random non-overlapping images were obtained at Â200 magnification with the use of a fluorescent microscope (DM RA2; Leica Microsystems GmbH, Wetzlar, Germany) followed by manual counting of BrdU-positive signals in 500 cells per sample. Each experiment was performed in duplicate or triplicate and was repeated three times. Data were expressed as percentage of BrdU-DAPI ratio.
Apoptosis Assay
Apoptosis was assessed using a fluorescein TUNEL kit (Roche Applied Science, Penzberg, Upper Bavaria, Germany), according to manufacturer's instructions. To sensitize cells with H 2 O 2 before apoptosis assessment, cells were incubated with 50 mmol/L H 2 O 2 in growth medium for 2 hours. In brief, paraformaldehyde-fixed cells on coverslips or rehydrated formalin-fixed, paraffin-embedded (FFPE) mouse kidney sections were permeabilized with 0.1% Triton X-100 in 10 mmol/L sodium citrate (pH 6.0), followed by incubation with TUNEL reaction mixture for 1 hour at 37 C. Samples were counterstained with DAPI and mounted in Mowiol 4-88 reagent (Calbiochem). Random non-overlapping images were obtained at Â200 magnification using a fluorescent microscope (DM RA2; Leica) followed by manual counting of TUNEL-positive signals in 500 cells per sample for the cell experiments or in 8 to 10 high-power fields per sample for the tissue experiments. Each experiment was performed in duplicate or triplicate and was repeated two or three times. Cell data were expressed as percentage of TUNEL-DAPI counts, and tissue data were expressed as tubular TUNEL counts per high-power field.
For double staining, FFPE rat kidney sections were stained with TUNEL as described, followed by immunofluorescence labeling with anti-CRT antibody.
Cleaved-caspase 3 staining was also indicative of apoptosis in cultured cells (see Immunofluorescence).
Motility Assay
Cell motility was assessed using a wound-healing closure assay. The cells were cultured in 48-well plates in duplicate until they reached confluence. Then the growth medium was replaced with serum-deprived medium at 24 hours before wound induction. Three hours before wound induction, mitomycin C was added to the cells at a final concentration of 10 mg/mL in serum-deprived medium, to stop cell proliferation. To create the wound, a plastic pipette tip was gently drawn across the center of the well to produce a clean ). The experiment was repeated three times. Data were expressed as the percentage of the remaining wounded area at each time point.
Immunofluorescence
Cells were seeded on coverslips in 24-well plates in duplicate and cultured for 24 to 48 hours. To induce oxidative stress before cleaved caspase-3 staining, cells were incubated with 50 mmol/L H 2 O 2 in growth medium for 2 hours. The coverslips were removed from the wells, and the cells were fixed in 4% paraformaldehyde, blocked with a 5% FBS solution, incubated with primary antibodies to collagen IV (C1926; Sigma) or cleaved caspase-3 (catalog No. 9661; Cell Signaling Technology), developed using Alexa Fluor fluorescent secondary antibodies (Invitrogen), counterstained with DAPI, and mounted in Mowiol 4-88 reagent (Calbiochem). Random nonoverlapping images were obtained at Â200 magnification using a fluorescent microscope (Leica DM RA2). For quantification of cleaved caspase-3 staining, 500 cells per sample were manually counted. The experiments were repeated three times.
For dual immunolabeling, FFPE rat kidney sections were rehydrated, treated for antigen retrieval with 10 mmol/L sodium citrate (pH 6.0) at 100 C for 10 minutes, blocked with a 10% FBS solution, incubated with primary antibodies to GRP78 (AP06149PU-N; Acris Antibodies)/CRT (catalog No. 06-661; Upstate Biotechnology) or CRT alone after TUNEL staining, developed using Alexa Fluor fluorescent secondary antibodies (Invitrogen), counterstained with DAPI, and mounted in Mowiol 4-88 reagent (Calbiochem). Double immunofluorescence images were obtained using a Leica inverted confocal microscope.
For a-SMA immunostaining, FFPE mouse kidney sections were rehydrated, treated for antigen retrieval with 10 mmol/L sodium citrate (pH 6.0) at 80 C for 20 minutes, blocked with a 10% FBS solution, incubated with antie a-SMA primary antibody (Abcam), developed using Alexa Fluor fluorescent secondary antibody (Invitrogen), counterstained with DAPI, and mounted in Mowiol 4-88 reagent (Calbiochem). Non-overlapping images of the entire cortex were obtained using a Leica inverted confocal microscope at Â400 magnification. The a-SMAepositive area (expressed as percentage of total area excluding large vessels) was quantified in all of the images using publicly available image processing software (ImageJ Fiji; NIH
Q6
).
Histology
FFPE kidney sections stained with Sirius Red were used for histologic analysis. Slides were examined, and nonoverlapping images of the entire cortex were obtained using a Leica DM LS2 microscope and a Leica DFC 500 camera at Â400 magnification. The tubulointerstitial area stained (expressed as percentage of total area excluding glomeruli and large vessels) was quantified in all of the images using ImageJ Fiji.
Statistical Analysis
Results are presented as means AE SD. To analyze the difference between two data sets, the two-tailed Student's t-test was used, and for multiple group comparisons, analysis of variance with post hoc analysis. P < 0.05 was considered significant.
Results
Altered CRT Expression in TECs Influences Their Motility, Stress, Apoptosis, and Proliferation
To understand how CRT up-regulation in the tubular cells of the kidney affects the progression of fibrosis, we analyzed the phenotype of both CRT-overexpressing and CRT knockdown TECs. For overexpression, we used an established proximal TEC line (HK-2) and created HK-2 cell lines that stably overexpressed mouse CRT cDNA, using one cell line with low and one with high CRT overexpression, as well as one control line transfected with the control vector ( Figure 1 
½F1 ½F1
A). Compensatory down-regulation of the human CRT transcript was observed for the cell line with the greater total CRT expression, possibly explaining why higher overexpression folds were not achieved (Supplemental Figure S1 ). For knockdown, we created 373  374  375  376  377  378  379  380  381  382  383  384  385  386  387  388  389  390  391  392  393  394  395  396  397  398  399  400  401  402  403  404  405  406  407  408  409  410  411  412  413  414  415  416  417  418  419  420  421  422  423  424  425  426  427  428  429  430  431  432  433  434  435   436  437  438  439  440  441  442  443  444  445  446  447  448  449  450  451  452  453  454  455  456  457  458  459  460  461  462  463  464  465  466  467  468  469  470  471  472  473  474  475  476  477  478  479  480  481  482  483  484  485  486  487  488  489  490  491  492  493  494  495  496 HK-2 cell lines that stably expressed an shRNA molecule specifically targeting human CRT and used two cell lines with significant knockdown of CRT expression and one control line transfected with the empty vector ( Figure 1B) . It was observed that, compared with control cells, CRToverexpressing TECs were more elongated and mesenchymallike and adhered more loosely to each other ( Figure 2 ½F2 ½F2 A). Next we examined motility using a wound-healing closure assay. Compared with control cells, CRT-overexpressing cell lines displayed significantly increased motility up to 72 hours after wound induction, proportional to the level of CRT expression ( Figure 2B ). This phenomenon was not due to an increase in proliferation rate because mitomycin C was added to the assay to differentiate proliferation from migration. Moreover, in BrdU-incorporation assays, the overexpressing cell lines showed reduced proliferation ( Figure 2C ). The smaller total number of DAPI nuclei counted in CRT-overexpressing cells compared with control cells (Figure 2C ) suggests that the overexpressing cells proliferate more slowly.
Next we studied the intracellular stress state by examining the expression levels of GRP78, a major ER stress sensor. 16 CRT-overexpressing cells displayed significantly increased levels of GRP78, showing that CRT up-regulation induces ER stress response mechanisms ( Figure 3 ½F3 ½F3 A). Inasmuch as ER stress progression can lead to apoptosis and cell death, 17 we assessed the levels of cellular apoptosis using the TUNEL assay, which detects DNA fragmentation. Compared with control cells, CRT-overexpressing cells showed a twofold increase in apoptosis under normal culture conditions. After treatment with H 2 O 2 , apoptosis of the overexpressing cells was dramatically increased, in particular for the clone with greater CRT expression ( Figure 3B ). The total number of DAPI-positive cells counted for the TUNEL assay was reduced in the overexpressing cells compared with control cells, in particular after treatment with H 2 O 2 ( Figure 3B ), which suggests that CRT overexpressors died massively in response to H 2 O 2 . In addition, cleaved caspase-3 expression, which detects activation of the execution phase of apoptosis, assessed via immunostaining, was increased in the overexpressing cells in the absence or presence of H 2 O 2 in the growth medium ( Figure 3C ). The difference between cleaved caspase3epositive and TUNEL-positive cells after H 2 O 2 treatment may indicate that there are caspase-3eindependent mechanisms that induce DNA fragmentation in the CRT Representative blot shows increased GRP78 expression in CRT knockdown cells. Quantification corresponds to means AE SD of three independent experiments. *P < 0.05, **P < 0.01, and ***P < 0.001 versus control.
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In the CRT knockdown cells, a significant increase in GRP78 levels was also observed (Figure 3D ), probably to compensate for the considerable CRT suppression. However, the function of GRP78 and the purpose of ER stress induction likely differ between CRT knockdown and overexpressing cells. Consistently, CRT knockdown cells did not display any important change in apoptosis or viability rates in TUNEL, caspase-3, or BrdU assays, features that could be influenced by ER stress (data not shown). It seems that reduction of CRT levels is not so crucial for proliferation and apoptosis of TECs as is its overexpression. Moreover, the unaltered activated caspase-3 expression may account for the failure to observe protection from apoptosis of the CRT knockdown cells (data not shown).
CRT Overexpression or Knockdown in TECs Alters Expression of Epithelial and Mesenchymal Markers
Because progression of fibrosis has been associated with changes in the epithelial cell phenotype, 5, 6 we examined the expression levels of epithelial and mesenchymal protein markers in both CRT-overexpressing and knockdown TECs. The epithelial junctional protein E-cadherin was substantially decreased in the overexpressing cells. In parallel, mesenchymal proteins such as vinculin and vimentin were increased ( Figure 4 ½F4 ½F4 A). These results showed that CRT upregulation causes a decline of the epithelial cell phenotype in favor of a more mesenchymal character.
To confirm previous findings, we further characterized several markers at the gene expression level. E-cadherin and vimentin expression followed the same pattern as did protein expression ( Figure 4B ). Snai1 (snail) and Snai2 (slug), two transcriptional repressors of E-cadherin and strong inducers of EMT, 18e20 were significantly up-regulated in CRToverexpressing cells. However, expression levels of Acta2 (the gene name for a-SMA), the most commonly used marker for myofibroblasts, were decreased in the CRT overexpressors, indicating that despite their phenotypic change, CRT-overexpressing TECs are not promoted to reach EMT.
CRT knockdown led to an important increase in E-cadherin expression at both the protein ( Figure 4C ) and mRNA ( Figure 4D ) levels, showing the opposite phenotype as the overexpressing TECs. Other EMT markers such as Snai1 and Acta2 were not changed by CRT suppression ( Figure 4D ). However, induction of both Snai1 and Acta2 after TGF-b1 treatment was completely abolished in the CRT knockdown TECs. Furthermore, suppression of E-cadherin induced by TGF-b1 was partially attenuated ( Figure 4D ). These results show that down-regulation of CRT expression inhibits several TGF-b1edriven responses of epithelial cells in culture, supporting a profibrotic role of CRT.
Altered CRT Expression Levels Change the Secretory Profile of TECs
As fibrosis development is highly based on ECM accumulation, we tested whether CRT up-regulation or knockdown in TECs affects the production of ECM components. Fibronectin expression was significantly increased in the CRToverexpressing cells, at both the protein and mRNA levels ( Figure 5 
½F5 ½F5
, A and D). In addition, collagen IV, an epithelial collagen type and basic component of the tubular basement membrane, was notably up-regulated in the CRT overexpressors at both the protein and mRNA expression levels ( Figure 5, B and D) . However, collagen I, which is known to The lanes were run on the same gel but were noncontinguous. Quantification corresponds to means AE SD of three independent experiments. B: Relative mRNA amount (RT-qPCR) of several EMT markers (E-cadherin, Vimentin, Acta2, Snai1, Snai2) in control and CRT-overexpressing cells. C: Representative blot of E-cadherin expression in TECs underexpressing CRT with or without TGF-b1 treatment. E-cadherin is remarkably increased in knockdown cells, and its suppression by TGF-b1 is compromised. D: Relative mRNA amount of TGF-b1 response genes in CRT knockdown cells. CRT suppression impairs TGF-b1 signaling in TECs. Data represent means AE SD of three independent experiments. *P < 0.05, **P < 0.01, and ***P < 0.001 versus control; 621  622  623  624  625  626  627  628  629  630  631  632  633  634  635  636  637  638  639  640  641  642  643  644  645  646  647  648  649  650  651  652  653  654  655  656  657  658  659  660  661  662  663  664  665  666  667  668  669  670  671  672  673  674  675  676  677  678  679  680  681  682  683   684  685  686  687  688  689  690  691  692  693  694  695  696  697  698  699  700  701  702  703  704  705  706  707  708  709  710  711  712  713  714  715  716  717  718  719  720  721  722  723  724  725  726  727  728  729  730  731  732  733  734  735  736  737  738  739  740  741  742  743  744 be produced by fibroblasts, was not increased in TECs overexpressing CRT, neither at the protein (conditioned medium, cell, and ECM fractions) nor at the transcript level ( Figure 5 , C and D). That Col1A1 was completely absent from the ECM fraction of TECs is in total agreement with the epithelial character of the well-differentiated cell line used and the composition of the renal tubular basement membrane. In contrast, CRT knockdown led to a dramatic decrease in Col1a1 expression, without significantly affecting expression of Fn1 or Col4a1 transcripts ( Figure 5E ). These results indicate that CRT overexpression in TECs promotes selective production of ECM components without inducing complete mesenchymal transformation of TECs; however, its suppression is able to attenuate the expression of primary mesenchymal markers such as Col1a1.
CRT-Overexpressing Tubular Cells in Vivo Display Increased Cellular Stress
Cellular stress originating from ER is increasingly recognized as a major mechanism contributing to the progression of renal fibrosis. 21 Because we found that CRT up-regulation in cultured TECs induces ER stress, we sought to confirm whether tubular cells overexpressing CRT in vivo in the UUO model display similar characteristics. Thus, we performed double immunofluorescence staining of kidney sections from control (sham-operated) mice and at 2 or 8 days in animals who underwent ureter ligation (L2 and L8, respectively). GRP78, an indicator of ER stress, and CRT were expressed at relatively low levels in control animals ( Figure 6 ½F6 ½F6 ). However, the level of both proteins gradually increased at 2 and 8 days after ureteric obstruction and displayed broad co-localization in the tubular cells of the fibrotic kidney.
CRT Heterozygous Mice Demonstrate Improved Kidney Appearance and Reduced Collagen Accumulation in the UUO Model
Because our observations indicated that CRT up-regulation in TECs induces a profibrotic cell phenotype, we used an animal model with reduced CRT expression, mice heterozygous for CRT, 14 to directly investigate its role in fibrosis progression in the UUO model.
Initially, we confirmed that heterozygous mice produce approximately half the amount of CRT as their WT littermates do ( Figure 7 
½F7 ½F7
A). To analyze late stages of the disease progression, mice were sacrificed at days 8 and 17 after UUO. Ponceau S staining was used as loading control. COL1A1, a fibroblast-specific collagen, is not increased by CRT up-regulation in TECs. D: Relative mRNA amount (RT-qPCR) of Col1a1, Col4a1, and Fibronectin. Transcript levels follow the same pattern as protein expression. E: Relative mRNA amount (RT-qPCR) of ECM molecules in CRT knockdown TECs shows significant suppression of Col1a1 and no change in Col4a1 and Fn1. Data represent means AE SD of three independent experiments. *P < 0.05, **P < 0.01, and ***P < 0.001 versus control. Scale bars: 100 mm (B).
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To further investigate whether CRT reduction affects ECM deposition during tissue fibrosis, we performed Sirius Red staining of kidney sections from WT and heterozygous mice. Quantification of the extent of Sirius Red staining showed that there was substantially reduced collagen accumulation in the kidneys of heterozygous mice, both at 8 and 17 days after UUO ( Figure 7C ). Collagen accumulation was decreased by 35% at 8 days and by 50% at 17 days, indicating that reduction in CRT expression protects from ECM deposition up to very late stages of fibrosis progression.
CRT Heterozygous Mice Demonstrate Altered Expression of Key Molecules That Regulate Progression of Fibrosis
We then examined the expression levels of several major profibrotic and proinflammatory molecules along with the expression levels of CRT in the mouse UUO model.
RT-qPCR analysis showed that CRT was up-regulated with progression of fibrosis but was significantly reduced in heterozygous mice compared with WT mice. However, greater reduction was observed at 17 days after obstruction, indicating that CRT expression in heterozygous mice was not proportionally reduced at all time points (Figure 8 
½F8 ½F8
A). In accordance with CRT expression levels, the profibrotic genes examined, including the ECM components Col1a1, Col3a1, Col4a1, and Fn1 (fibronectin), the profibrotic growth factor TGF-b1, and the transcription factors Snai1 and Snai2, were notably attenuated in heterozygous mice, but to a lesser extent at 8 days than at 17 days after UUO ( Figure 8B ). Moreover, examination of the expression levels of E-cadherin as a marker of epithelial integrity revealed an important reduction in WT mice at 17 days after obstruction, whereas its expression was not altered in heterozygous mice ( Figure 8C ). Next, we determined the area of a-SMAe positive myofibroblasts and the expression levels of the proinflammatory mediators TNF-a and MCP1. At 17 days after obstruction, both a-SMA and proinflammatory gene expression were significantly attenuated in heterozygous mice, comparable to the level of CRT reduction (Figure 8 , D and E). In summary, these results indicate that CRT may positively regulate activation of profibrotic and proinflammatory pathways and that reduction of its levels is able to efficiently attenuate the progression of fibrosis.
Renal Tubular Cells in CRT Heterozygous Mice Are Protected from Apoptosis during Fibrosis Progression
Because apoptosis has a major role in tubular cell loss during fibrosis development, 5, 22 we investigated whether reduction of CRT affects tubular apoptosis in the UUO model. TUNEL staining of kidney sections showed that, compared with WT mice, CRT heterozygous mice demonstrate markedly less tubular apoptosis at both 8 and 17 days after obstruction (Figure 9 
½F9 ½F9
). This decrease in tubular apoptosis is comparable to the expression level of CRT after UUO ( Figure 8A ).
CRT Levels Affect Expression of Molecules Being Upstream or Downstream TGF-b1 Signaling
Inasmuch as CRT partial deficiency in heterozygous mice repressed expression of TGF-b1, a key mediator of profibrotic events, we investigated whether CRT may regulate TGF-b1 production and/or activation.
Thrombospondin 1 (TSP1) is a complex matricellular protein that regulates latent TGF-b1 activation and has a role during tissue repair and fibrosis. 23, 24 We showed that TSP1 was up-regulated along with development of fibrosis, yet its expression was significantly reduced in CRT heterozygous mice compared with WT littermates at both time points examined (Figure 10 869  870  871  872  873  874  875  876  877  878  879  880  881  882  883  884  885  886  887  888  889  890  891  892  893  894  895  896  897  898  899  900  901  902  903  904  905  906  907  908  909  910  911  912  913  914  915  916  917  918  919  920  921  922  923  924  925  926  927  928  929  930  931 induces a proportional increase in TSP1 expression levels ( Figure 10B ). Experiments performed on CRT-knockdown TECs showed that CRT deficiency reduces TSP1 expression significantly ( Figure 10C ). These results collectively indicate that CRT levels directly affect TSP1 expression and thus may regulate TSP1-mediated TGF-b1 activation. Furthermore, we investigated the effect of CRT levels on expression of proinflammatory mediators because inflammatory cells represent the major source of TGF-b1 in fibrosis. 25 All three cytokines examined (MCP1, TNF-a, and IL-8) were remarkably increased in the CRToverexpressing TECs ( Figure 10D ). In contrast, MCP1 and TNF-a were significantly reduced in CRT knockdown TECs ( Figure 10C ). This is consistent with repression of MCP1 and TNF-a levels in CRT heterozygous mice during fibrosis progression ( Figure 8E ) and associates CRT with regulation of inflammation and consequently TGF-b1 production.
In agreement with these findings, we showed that phosphorylated Smad3, a central mediator of TGF-b1 signaling, is substantially attenuated in CRT heterozygous mice at both time points of fibrosis, clearly indicating lower activation of the TGF-b1 pathway ( Figure 10E ).
Discussion
Renal fibrosis is the common anatomical denominator underlying the progression of CKD of various causes. 3 Only a detailed understanding of the mechanisms and macromolecules involved in fibrosis progression will enable development of targeted therapeutic interventions. In this report, we demonstrated participation of CRT during development of renal fibrosis in vitro and in vivo. Our studies in vitro with renal TECs showed that CRT upregulation was a causative factor for acquisition of an altered, primarily profibrotic cellular phenotype. Next, we confirmed that critical changes observed in vitro (cellular stress and apoptosis) were also appearing in tubular cells in vivo in the animal model of UUO. On the basis of these observations, we reasoned that reduction of CRT may exert a protective effect toward fibrosis. Indeed, we demonstrated that substantial reduction in expression of CRT in heterozygous transgenic mice impressively attenuated the progression of tubulointerstitial fibrosis.
How does CRT up-regulation in tubular cells affect progression of renal fibrosis? Overexpression of CRT in cultured renal TECs caused the decrease of differentiated epithelial cell markers (eg, E-cadherin) and acquisition of showed substantially reduced collagen deposition in the kidneys of heterozygous mice at both time points. n Z 3 per group. The tubulointerstitial area stained was quantified in non-overlapping images of the entire cortex. **P < 0.01 versus WT; y P < 0.05 versus L8WT; zz P < 0.01 versus L17WT. Scale bars: 50 mm (C).
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a more mesenchymal phenotype, most likely through upregulation of the key EMT regulators Snai1 and Snai2 (Figure 4) . 18e20 That the low CRT overexpression caused a greater decrease in E-cadherin expression is in total agreement with the greater increase in Snai1 levels and stronger activation of the b-catenin pathway in the overexpression 1 clone (data not shown). These results may indicate that slight changes in CRT expression may be able to disproportionally affect certain pathways at the cell culture level and that fine tuning of CRT levels intracellularly may be important for cellular functions. However, in the case of a complex tissue in which other factors and cell types are also involved, these effects may be counterbalanced. In agreement with these findings, a previous study of Madin-Darby canine kidney cells evaluated the role of CRT in induction of EMT. 26 EMT previously has been proposed to have a pivotal contribution to development of renal fibrosis. 20, 27 However, recent studies have challenged this notion and have rendered the role of EMT highly controversial. 28, 29 Interestingly, our results showed that CRT overexpression in TECs did not induce expression of either Acta2 (the gene coding for a-SMA), the most commonly used marker for activated fibroblasts and myofibroblasts, or Col1a1, the major collagen type produced by fibroblasts. Previous studies of fibroblast cell lines have proportionally correlated CRT abundance with collagen I expression and deposition into the ECM. 15 These results, combined with our findings, indicate that CRT may regulate certain cellular functions in a cell typeespecific manner. For example, CRT up-regulation in TECs enhanced production 1117  1118  1119  1120  1121  1122  1123  1124  1125  1126  1127  1128  1129  1130  1131  1132  1133  1134  1135  1136  1137  1138  1139  1140  1141  1142  1143  1144  1145  1146  1147  1148  1149  1150  1151  1152  1153  1154  1155  1156  1157  1158  1159  1160  1161  1162  1163  1164  1165  1166  1167  1168  1169  1170  1171  1172  1173  1174  1175  1176  1177  1178  1179   1180  1181  1182  1183  1184  1185  1186  1187  1188  1189  1190  1191  1192  1193  1194  1195  1196  1197  1198  1199  1200  1201  1202  1203  1204  1205  1206  1207  1208  1209  1210  1211  1212  1213  1214  1215  1216  1217  1218  1219  1220  1221  1222  1223  1224  1225  1226  1227  1228  1229  1230  1231  1232  1233  1234  1235  1236  1237  1238  1239  1240 of other ECM components including fibronectin and collagen IV, which are not fibroblast specific. These data suggest that CRT up-regulation initiates epithelial plasticity, which may facilitate tubular cells to adjust to their fibrotic environment; however, it is in itself insufficient for full myofibroblastic differentiation of epithelial cells, which can be promoted in vitro by other factors such as TGF-b1. That CRT repression in TECs suppressed both TGF-b1 responses and Col1a1 expression shows that CRT promotes fibrotic pathways and that its reduction is able to attenuate expression of several fibrotic markers. In agreement with these findings, it was shown that knockdown of CRT in fibroblast cell lines attenuates TGF-b1einduced ECM production. 30 In accordance with this alteration of cell phenotype was acquisition of a more elongated architecture and increased motility of the CRT-overexpressing TECs. Previous studies of several cell lines have yielded contradictory results insofar as the role of CRT in wound healing and modulation of cell adhesiveness.
31e35 For example, CRT overexpression in fibroblasts enhanced cell attachment efficacy on fibronectin-coated matrices and reduced cell motility. 31 In contrast, in vitro treatment with exogenous CRT increased proliferation and migration of both epithelial cells and fibroblasts. 35 The decreased proliferation rate of CRToverexpressing TECs in the present study can be attributed to the fact that endogenous ER resident CRT may exert different functions from exogenously added CRT. Furthermore, it is possible that the influence of CRT on cell motility differs between epithelial cells and fibroblasts. Induction of Tsp1 in CRT-overexpressing TECs, which promotes focal adhesion disassembly and cell migration, 23, 33 may have a role in the increased motility observed in CRT overexpressors.
ER stress and apoptosis are increasingly appreciated as major contributors to progression of renal fibrosis. 21, 22 CRT, apart from its other cellular functions, serves as an ER stress response protein, being up-regulated by various stress stimuli. 36, 37 Moreover, separate studies of a variety of cell lines have attributed opposing roles to CRT in regulation of apoptosis.
38e44 For example, certain studies have proportionally correlated CRT abundance with increased cell sensitivity to apoptosis, 38e41 whereas others have positively associated CRT expression with protection from apoptosis induced by diverse stimuli such as nitric oxide, hypoxia, or intracellular Ca 2þ overload. 42e44 It is possible that the effect of CRT on viability and apoptosis differs according to the cell line used, the level of CRT expression, or the severity and duration of the apoptotic stimulus. In the present study, CRT overexpression in TECs aggravated the ER stress state and rendered the cells prone to apoptotic death. In addition to the data presented for GRP78, our preliminary studies indicated that phosphorylation of the eukaryotic initiation 
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The American Journal of Pathology -ajp.amjpathol.org 11 factor 2a (peIF2a), a crucial step in the stress-induced signaling pathways, 16, 17 is increased in CRToverexpressing TECs (data not shown). CRT knockdown in TECs also induced prominent up-regulation of GRP78 expression. This is consistent with the increased expression of ER stress proteins, including GRP78 observed in CRTnull mouse embryonic fibroblasts. 45 These data suggest that CRT deficiency triggers an ER stress response to compensate for accumulation of unfolded proteins and to facilitate the protein quality control chaperoned in the ER. In contrast, ER stress proteins also regulate fibrotic processes. 46 Our results suggest that CRT overexpression in TECs induced an ER stress response, in particular accompanied by fibrotic changes and apoptosis, alterations that were not observed in CRT knockdown TECs despite increased expression of GRP78. Consistently, we confirmed the existence of broad ER stress in the CRT-overexpressing tubular cells in vivo in the UUO model, in which a high degree of co-distribution was noted. These observations support the idea that CRT may contribute to renal fibrosis through ER stress and apoptosis induction.
Because CRT up-regulation in TECs causes phenotypic alterations that may be considered crucial steps during the progression of fibrosis, can reduction of its expression have protective effects on fibrosis development? In that deletion of the CRT gene causes embryonic lethality, 14 the use of heterozygous transgenic mice, with an approximately 50% reduction in CRT expression, was an ideal tool for directly investigating the role of CRT in fibrosis. Although CRT was up-regulated in the UUO model, as expected, its expression in heterozygous mice was not proportionally reduced, showing a greater decrease at 17 days of obstruction. It is possible that the need for increased CRT expression led to greater up-regulation of the single CRT allele in heterozygous mice in the early stages of fibrosis, which could not be sustained to the later stages of the disease. Apparently, the reduced expression of CRT in heterozygous mice is not restricted to tubules, in which CRT is specifically upregulated in the UUO model of fibrosis. 9 The possibility that decreased CRT expression in other cell types, including interstitial fibroblasts and immune cells, also affects the progression of fibrosis cannot be excluded. However, the specific function of CRT in these cell types has been extensively examined in other studies and is under discussion.
In accordance with our hypothesis, CRT deficiency notably improved the gross appearance of the ligated kidneys, seen macroscopically with less dilatation and better color preservation as compared with WT kidneys. This delay of the fibrotic process was further established and quantitated via Sirius Red staining, which verified that the kidneys of heterozygous mice had substantially reduced ECM accumulation at both time intervals (ie, starting at day 8) and that this reduction was even more dramatic at 17 days after UUO. The observation of a 35% reduction in Sirius Red staining at 8 days after UUO accompanied by a smaller 20% decrease in CRT transcript can be attributed to the fact that CRT expression level corresponds to the specific time point examined, whereas the area of Sirius Red staining represents the total amount of ECM accumulated from onset of the disease. Accordingly, the area of a-SMAepositive myofibroblasts and the expression levels of all ECM molecules examined were attenuated in heterozygous mice, most significantly at 17 days after UUO, in accordance with the greater reduction in CRT levels. In addition to the decrease in ECM accumulation, CRT heterozygous mice exhibited better preservation of the tubular structure, evidenced by the maintenance of E-cadherin expression and attenuation of tubular apoptosis. Consistently, the transcriptional regulators of EMT and fibrosis, Snai1 and Snai2, were repressed in heterozygous mice. These results are confirmed by our findings in cultured TECs and suggest that CRT affects profibrotic pathways, at least in part, by inducing major transcriptional regulators of fibrosis such as Snai1 and Snai2.
A central mediator in these pathways is the profibrotic cytokine TGF-b1, the expression of which was attenuated in CRT heterozygous mice. TGF-b1 mediates several key pathologic events during CKD progression, including fibroblast activation, tubular and fibroblast ECM production, epithelial cell death, and inflammatory processes, and the disruption of its signaling impeded development of chronic renal damage. 47, 48 The major source of TGF-b1 during fibrosis is the infiltrating inflammatory cells. 25 Apparently, inflammation was attenuated in heterozygous mice, as demonstrated by the decrease in inflammatory mediators (MCP1 and TNF-a) and the smaller perivascular infiltrates observed (data not shown). In TECs overexpressing CRT, several inflammatory cytokines were induced (MCP1, TNF-a, and IL-8), which suggests that epithelial up-regulation of CRT during fibrosis may be involved in establishment of the inflammatory state that characterizes the fibrotic kidney, thereby increasing TGF-b1 production. Consistently, a number of immunologic functions have already been ascribed to CRT. Cell surface expression of CRT promotes the phagocytic uptake of dying cells, assists in maturation of immune cells, and enhances lymphocyte infiltration of tumors.
49e52 That the cell surface form of CRT promotes clearance of apoptotic cells does not contradict the reduced tubular apoptosis observed in heterozygous mice because it is possible that the decrease in ER resident CRT attenuates tubular apoptosis. In addition, CRT possibly may regulate TGF-b1 activation by directly affecting expression of TSP1, an endogenous TGF-b1 activator, as shown by the prominent up-regulation of TSP1 in TECs overexpressing CRT and the impressive suppression of TSP1 in knockdown TECs. This result may seem contradictory to the increased levels of TSP1 transcript observed in CRT-null mouse embryonic fibroblasts 15 ; however, this may be another example of cell typeespecific phenomenon, highlighting the difference between the responses of epithelial cells and fibroblasts. Moreover, the cell surface form of CRT binds to TSP1 and stimulates events associated with wound healing including cell migration, anoikis resistance, and matrix deposition, which may also represent a mechanism through which CRT affects fibrosis.
23,33,52 TSP1 expression was repressed in CRT heterozygous mice both at earlier and later intervals, implying that TGF-b1 activation was alleviated. Reduced TGF-b1 activation was evidenced by the significant decrease in phosphorylated Smad3 levels at both time points in heterozygous mice. Therefore, we suggest that CRT deficiency attenuates progression of fibrosis by suppressing both TGF-b1 expression and activation and by hampering TGF-b1 responses, as demonstrated in CRT knockdown TECs.
Conclusion
Results of the present study demonstrate that overexpression of CRT in TECs is a critical regulator of several aspects of tubulointerstitial fibrosis development. Reduction of CRT expression in transgenic heterozygous mice efficiently ameliorates progression of fibrosis by affecting inflammatory processes, TGF-b1 production and/or activation, transcriptional regulation of fibrotic molecules, and apoptosis. The ability of CRT to affect so many aspects of fibrosis indicates that decreasing CRT levels may represent a novel targeted and effective treatment against fibrosis and CKD. The mechanisms of fibrosis development in various organs may have pathways shared in common or differing in a tissue-specific manner. For example, in an animal model of bleomycin-induced lung fibrosis, CRT was also upregulated during fibrosis progression. 9 It is therefore possible that in organs other than the kidney the fibrotic process could be also targeted by reduction of the levels of CRT. 1554  1555  1556  1557  1558  1559  1560  1561  1562  1563  1564  1565  1566  1567  1568  1569  1570  1571  1572  1573  1574  1575  1576  1577  1578  1579  1580  1581  1582  1583  1584  1585  1586  1587  1588  1589  1590  1591  1592  1593  1594  1595  1596  1597  1598  1599  1600  1601  1602  1603  1604  1605  1606  1607  1608  1609  1610  1611  1612 
